Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
Viruses · 2023
DOI: 10.3390/v15061305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Jorge C G Blanco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sigmovir Biosystems Inc., Rockville, MD 20850, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is a significant threat to elderly populations and repeated infections that occur throughout life are poorly protective. To assess the role of prior RSV infections as well as elderly immune senescence on vaccine efficacy, we compared immune responses after virus-like particle (VLP) immunization of elderly cotton rats and young cotton rats, both previously RSV infected, in order to mimic the human population. We show that immunization of RSV-experienced young or elderly animals resulted in the same levels of anti-pre-F IgG, anti-G IgG, neutralizing antibody titers, and protection from challenge indicating that the delivery of F and G proteins in a VLP is equally effective in activation of protective responses in both elderly and young populations. Our results suggest that F and G protein-containing VLPs induce anti-RSV memory established in prior RSV infections equally well in both young and elderly animals and thus can be an effective vaccine for the elderly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sigmovir Biosystems Inc., Rockville, MD 20850, USA.
- Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
ORCID-Profile: Jorge C G Blanco, Trudy G Morrison
Förderung
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Blanco, J. C. G., Cullen, L. M., Kamali, A., Sylla, F. Y. D., Boukhvalova, M. S., & Morrison, T. G. (2023). Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. https://doi.org/10.3390/v15061305
Vancouver
Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. 2023. doi:10.3390/v15061305
BibTeX
@article{Blanco2023,
author = {Blanco, Jorge C G and Cullen, Lori M and Kamali, Arash and Sylla, Fatouomata Y D and Boukhvalova, Marina S and Morrison, Trudy G},
title = {Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15061305}
}
EUVIMED